Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re Dynavax Securities Litigation
Case Number:
4:16-cv-06690
See also:
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
June 05, 2018
Dynavax Hepatitis Vaccine Shareholder Suit Tossed Again
A California federal judge on Monday dismissed an investor class action against Dynavax Technologies Corp. for a second time, telling investors they could not take another stab at claiming the biopharmaceutical company caused share prices to plunge after misrepresenting the safety of its Heplisav vaccine for hepatitis B.
-
September 13, 2017
Dynavax Escapes Shareholder Suit Over Hepatitis Vaccine
A California federal court on Tuesday tossed a proposed class action alleging biopharmaceutical company Dynavax Technologies Corp. misrepresented the safety of its Heplisav vaccine for hepatitis B, eventually causing share prices to plunge.